2019 American Transplant Congress
A National Cohort Validation of Graft Outcomes of Elderly Kidney Transplant Recipients
Henry Ford Transplant Institute, Detroit, MI
*Purpose: Previous analyses comparing elderly kidney transplant recipients (KTR) to younger KTR found that elderly patients suffered higher rates of mortality, less biopsy-proven acute rejection…2019 American Transplant Congress
The Outcomes after an Infection in Older Liver Transplant Recipients is Comparable to Younger Adults
*Purpose: Solid organ transplantation is being increasingly offered to older patients with concurrent chronic medical conditions such as cardiovascular, cerebrovascular, and renal disease. Risk of…2019 American Transplant Congress
Good Outcomes of Octagenerian Kidney-Transplant Recipients: A Single-Center Experience
New York Presbyterian / Weill Cornell, New York, NY
*Purpose: Given the aging population of patients with end-stage renal disease, the transplant community is increasingly confronted with the challenge of evaluating elderly patients for…2019 American Transplant Congress
“Getting Life Back” – Kidney Transplantation in the Elderly Patient
*Purpose: The number of elderly patients developing end stage renal disease (ESRD) who are eligible for kidney transplantation (KTx) is increasing, but their transplant rate…2019 American Transplant Congress
Long-Term Outcomes of Older Kidney-Transplant Recipients: A Single-Center Experience
Weill Cornell Medical College, New York, NY
*Purpose: Given the aging population of patients with ESRD, and the high rates of associated mortality, at our center we perform an individualized risk assessment…2019 American Transplant Congress
Is Kidney Transplantation Actually a Cost-Effective Alternative Also for Older Patients?
*Purpose: We aimed to study the health economic effects of kidney transplantation in a population of kidney transplant candidates > 65 years of age.*Methods: We…2019 American Transplant Congress
Lung Transplantation in the Elderly Patients with Multi-Comorbidities
Temple University Health System / Lewis Katz School of Medicine, Philadelphia, PA
*Purpose: Recently there is an outstanding steadily increase in elderly patients above 70 years old who are referred to our center as potential candidates for…2019 American Transplant Congress
Basiliximab versus T-cell Depleting Induction Therapy in Elderly Kidney Transplant Recipients
MedStar Georgetown Transplant Institute, Washington, DC
*Purpose: The ideal induction therapy for elderly kidney transplant recipients is not known. Given concerns about increased risk of infection and malignancy and perceived decreased…2019 American Transplant Congress
Evaluating Potentially Inappropriate Prescribing in Older Kidney Transplant Recipients
*Purpose: While the Beers criteria (BC) and STOPP criteria (SC) have been validated in several patient populations to reduce medication use leading to adverse drug…2019 American Transplant Congress
Is Alemtuzumab Induction Safe In Septuagenarians Undergoing Deceased Donor Kidney Transplantation?
Wake Forest Baptist Medical Center, Winston-Salem, NC
*Purpose: Alemtuzumab induction in septuagenarians is controversial but understudied.*Methods: Single center retrospective review of adult deceased donor kidney transplant (KT) recipients receiving single dose (30…
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- …
- 17
- Next Page »